background image

Clinical Trials In Kansas

Discover hundreds of clinical trials in Kansas.
Search clinical trials in Kansas by city, condition or phase.

Filter
1

Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Little Rock, Germantown, Springdale, Shreveportshow 114 more

Code:

NCT06120491

Conditions

Metastatic Castration-Sensitive Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Saruparib

Placebo

Abiraterone Acetate

Darolutamide

Enzalutamide

Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)

Recruiting

Sponsor:

University of Kansas Medical Center

Location:

Dallas, Kansas City, Iowa City, Columbusshow 12 more

Code:

NCT04635891

Conditions

FSHD

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

Recruiting
PHASE3

Sponsor:

Bellus Health Inc. - a GSK company

Location:

Little Rock, Tulsa, McKinney, Columbiashow 67 more

Code:

NCT05599191

Conditions

Refractory Chronic Cough

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

BLU-5937

Placebo

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

Recruiting
PHASE1
PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Creve Coeur, Saint Louis, Shiloh, Saint Petersshow 11 more

Code:

NCT05691491

Conditions

Advanced Malignant Solid Neoplasm

Advanced Microsatellite Stable Colorectal Carcinoma

Hematopoietic and Lymphatic System Neoplasm

Metastatic Malignant Solid Neoplasm

Metastatic Microsatellite Stable Colorectal Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy

Biospecimen Collection

Computed Tomography

Magnetic Resonance Imaging

Temozolomide

Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)

Recruiting
PHASE2

Sponsor:

Edgewise Therapeutics, Inc.

Location:

Little Rock, Saint Louis, Denton, Kansas Cityshow 22 more

Code:

NCT05291091

Conditions

Becker Muscular Dystrophy

Eligibility Criteria

Sex: Male

Age: 12 - 50

Healthy Volunteers: Not accepted

Interventions

Sevasemten 10 mg

Sevasemten 5 mg

Sevasemten 12.5 mg

Placebo

Product Surveillance Registry

Recruiting

Sponsor:

Medtronic

Location:

Little Rock, Jonesboro, Memphis, Germantownshow 133 more

Code:

NCT01524276

Conditions

Cardiac Rhythm Disorders

Urological Disorders

Neurological Disorders

Cardiovascular Disorders

Digestive Disorders

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

EPPIC-Net: Platform Protocol to Assess Treatments for Painful Diabetic Peripheral Neuropathy

Recruiting
PHASE2

Sponsor:

James P. Rathmell, MD

Location:

Hazelwood, Kansas City, Houston, Flossmoorshow 16 more

Code:

NCT05476276

Conditions

Painful Diabetic Neuropathy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ISA specific

Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)

Recruiting
PHASE1
PHASE2

Sponsor:

UniQure Biopharma B.V.

Location:

Fairway, Atlanta, Chicago, Rochestershow 6 more

Code:

NCT06100276

Conditions

Amyotrophic Lateral Sclerosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AMT-162

A Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe Disease

Recruiting

Sponsor:

Astellas Gene Therapies

Location:

Kansas City, Ann Arbor, Minneapolis, Pittsburghshow 2 more

Code:

NCT06150820

Conditions

Pompe Disease (Late-onset)

Eligibility Criteria

Sex: All

Age: 16 - 69

Healthy Volunteers: Not accepted

Interventions

No Intervention

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Recruiting
PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Hot Springs, Fort Smith, Branson, Springfieldshow 351 more

Code:

NCT03866382

Conditions

Bladder Adenocarcinoma

Bladder Clear Cell Adenocarcinoma

Bladder Mixed Adenocarcinoma

Bladder Neuroendocrine Carcinoma

Bladder Small Cell Neuroendocrine Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Scan

Cabozantinib S-malate

Computed Tomography

Echocardiography

With a well-established healthcare network and renowned medical research institutions, Kansas has emerged as a significant hub for a wide range of clinical trials. Leading institutions such as The University of Kansas Medical Center, Wesley Medical Center, and Children's Mercy Kansas City are at the forefront of groundbreaking studies.

These centers are recognized for their contributions to innovative medical research, helping to advance treatments in fields such as oncology, cardiology, and pediatrics.

Why choose Kansas for clinical trials?

Common conditions studied in Kansas

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Kansas